asimadoline has been researched along with levallorphan in 1 studies
| Studies (asimadoline) | Trials (asimadoline) | Recent Studies (post-2010) (asimadoline) | Studies (levallorphan) | Trials (levallorphan) | Recent Studies (post-2010) (levallorphan) |
|---|---|---|---|---|---|
| 43 | 9 | 11 | 413 | 13 | 12 |
| Protein | Taxonomy | asimadoline (IC50) | levallorphan (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0008 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
1 other study(ies) available for asimadoline and levallorphan
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |